NCT04821869View on ClinicalTrials.gov

ProAir Digihaler in COPD Disease Management: A Real World Study

CompletedOBSERVATIONAL
Enrollment

27

Participants

Timeline

Start Date

May 10, 2021

Primary Completion Date

June 21, 2022

Study Completion Date

June 21, 2022

Conditions
COPDCOPD Exacerbation Acute
Interventions
DRUG

ProAir Digihaler

Monitor parameters transmitted from the Proair Digihaler to the Digihaler Dashboard, including peak inspiratory Flow, inspiratory volume and frequency of rescue use

DEVICE

Digihaler

Monitor parameters transmitted from the Proair Digihaler to the Digihaler Dashboard, including peak inspiratory Flow, inspiratory volume and frequency of rescue use

Trial Locations (1)

48336

Pulmonary Research Institute of Southeast Michigan, Farmington Hills

All Listed Sponsors
collaborator

Teva Branded Pharmaceutical Products R&D, Inc.

INDUSTRY

lead

Pulmonary Research Institute of Southeast Michigan

OTHER